Analysis of survival at metastatic melanoma patients treated with vemurafenib - a three year single institution study
Naslov
Analysis of survival at metastatic melanoma patients treated with vemurafenib - a three year single institution study
Identifikator
/unibl/sci/idNaucniRad:36689
Tip
Pronađite slične unoseAcademic Article
Datum
Bibliografski citat
Z. Gojković, D. Đokanović, B. Jakovljević, S. Maksimović, S. Jungić, I. Rakita, M. Vještica, R. Rašeta, Ž. Vranješ, M. Štrbac, Analysis of survival at metastatic melanoma patients treated with vemurafenib - a three year single institution study, Scripta Medica, pp. 126 - 131, 2025
Početna stranica
126
Krajnja stranica
131
Je dio
Scripta Medica
2303-7954
Lista autora
Position: 168287 (6 views)